<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">27494616</PMID>
      <DateCompleted>
        <Year>2017</Year>
        <Month>07</Month>
        <Day>31</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1932-6203</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2016</Year>
            </PubDate>
          </JournalIssue>
          <Title>PloS one</Title>
          <ISOAbbreviation>PLoS One</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Emergence of Quinolone Resistant Shigella sonnei, Pondicherry, India.</ArticleTitle>
        <Pagination>
          <StartPage>e0160290</StartPage>
          <MedlinePgn>e0160290</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e0160290</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0160290</ELocationID>
        <Abstract>
          <AbstractText>Ciprofloxacin resistant Shigella sonnei across the globe have been increasing alarmingly. In order to understand the emergence of S.sonnei with respect to ciprofloxacin resistance in our patient population, the following study was carried out. Of the 184 Shigella sp. Isolated from 2012 to 2015, 34 S.sonnei which were confirmed by standard methods and subjected to antimicrobial susceptibility testing were selected. The minimum inhibitory concentrations (MICs) of 16/34 quinolone resistant isolates tested ranged from 4micrograms/ml to 16micrograms/ml for ciprofloxacin, from 16 micrograms/ml to 64 micrograms/ml for ofloxacin and from 16micrograms/ml to 64micrograms/ml for levofloxacin. Sequence determination of the quinolone resistance determining regions of gyrA, gyrB, parC, and parE genes showed mutations in GyrA at Gln69/Trp, Phe71/Ser, Ser72/Pro, Met75/Leu, Ser90/Cys, Met94/Leu, His106/Pro, Asn161/His, Thr163/Ala and in ParC at Ala64/Asp. Among the plasmid-mediated quinolone resistance (PMQRs) targets investigated,qnrB was the most (93.7%) prevalent followed by qnrC (18.7%). None hadqnrA, qnrS and qepA. Two (0.1%) of the isolates harboured theaac(6')-lb gene. Drug accumulation assay detected the presence of efflux pump activity in 9/15 (60%) among ciprofloxacin resistant isolates. All isolates harboured the ipaH gene followed by ial (17.6%), sen (11.7%), set1A&amp;set1B (5.8%) genes. None had stx1 element. PCR for Enterobacterial repetitive intergenic consensus (ERIC) sequences resulted in 4 unique clusters, of which Type III was the most (44%) dominant but there was no correlation between the ERIC types and the antibiotic resistance pattern or the virulence profile. A documented increase in S.sonnei harbouring the qnrgenes and some unusual genes like set1Aand indicate an ongoing process of horizontal gene transfer. The accumulation of novel mutations in GyrA and ParC in the presence of efflux pump and PMQR genes contributed to the raised MIC to quinolones. These findings are crucial in our understanding of quinolone resistance in these isolates.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Das</LastName>
            <ForeName>Ankita</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Natarajan</LastName>
            <ForeName>Mailan</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mandal</LastName>
            <ForeName>Jharna</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-5945-8425</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2016</Year>
          <Month>08</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>PLoS One</MedlineTA>
        <NlmUniqueID>101285081</NlmUniqueID>
        <ISSNLinking>1932-6203</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015363">Quinolones</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>5E8K9I0O4U</RegistryNumber>
          <NameOfSubstance UI="D002939">Ciprofloxacin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>6GNT3Y5LMF</RegistryNumber>
          <NameOfSubstance UI="D064704">Levofloxacin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001426" MajorTopicYN="N">Bacterial Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002939" MajorTopicYN="N">Ciprofloxacin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024881" MajorTopicYN="N">Drug Resistance, Bacterial</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004405" MajorTopicYN="N">Dysentery, Bacillary</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064704" MajorTopicYN="N">Levofloxacin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015363" MajorTopicYN="N">Quinolones</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012764" MajorTopicYN="N">Shigella sonnei</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
          <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2016</Year>
          <Month>4</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2016</Year>
          <Month>7</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2016</Year>
          <Month>8</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2016</Year>
          <Month>8</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>8</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">27494616</ArticleId>
        <ArticleId IdType="pmc">PMC4975386</ArticleId>
        <ArticleId IdType="doi">10.1371/journal.pone.0160290</ArticleId>
        <ArticleId IdType="pii">PONE-D-16-16328</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Weir E. Shigella: Wash your hands of the whole dirty business. Can Med Assoc J. 2002; 167: 281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC117478</ArticleId>
            <ArticleId IdType="pubmed">12186178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nandy S, Mitra U, Rajendran K, Dutta P, Dutta S. Subtype prevalence, plasmid profiles and growing fluoroquinolone resistance in Shigella from Kolkata, India (2001–2007): a hospital-based study. Tropical Medicine and International Health. 2010; 15:1499–1507. 10.1111/j.1365-3156.2010.02656.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-3156.2010.02656.x</ArticleId>
            <ArticleId IdType="pubmed">20955371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>von Seidlein L, Kim DR, Ali M, Lee H, Wang X, Thiem VD, et al.
A multicenter study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med. 2006;3:e353
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1564174</ArticleId>
            <ArticleId IdType="pubmed">16968124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vinh H, Nhu NTK, Nga TVT, Duy PT, Campbell JI, Hoang NVM, et al.
A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infect Dis. 2009;9:204
10.1186/1471-2334-9-204
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2334-9-204</ArticleId>
            <ArticleId IdType="pmc">PMC2803792</ArticleId>
            <ArticleId IdType="pubmed">20003464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>The HC, Thanh DP, Holt KE, Thomson NR, Baker S. The genomic signatures of Shigella evolution, adaptation and geographical spread. Nature reviews Microbiology. 2016;14: 235–250. 10.1038/nrmicro.2016.10
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro.2016.10</ArticleId>
            <ArticleId IdType="pubmed">26923111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bopp CA, Brenner FW, Fields PL, Wells JG, Strockbine NA. Escherichia, Shigella, and Salmonella
Murray PR, Baron EJ, Jorgensen J, Pfaller MA, Yolken R H(Eds.), Manual of clinical microbiology (8th ed.), American Society for Microbiology, Washington, DC:  (2003), pp. 654–671.</Citation>
        </Reference>
        <Reference>
          <Citation>CLSI. Performance standards for antimicrobial susceptibility testing. Twenty-fourth Informational Supplement
CLSI document M100–S24. Wayne, PA: Clinical and Laboratory Standards Institute; 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Sangeetha AV, Parija SC, Mandal J, Krishnamurthy S. Clinical and Microbiological Profiles ofShigellosis in Children.J Health PopulNutr
2014;32:580–586.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4438687</ArticleId>
            <ArticleId IdType="pubmed">25895190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bonkoungou IJO, Lienemann T, Martikainen O, Dembele R, Sanou I, Traore AS, et al.
Diarrhoeagenic Escherichia coli detected by 16-plex PCR in children with and without diarrhoea in Burkina Faso. ClinMicrobiol Infect
2012;18: 901–906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21985619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>López-Saucedo C, Cerna JF, Villegas-Sepulveda N, Thompson R, Velazquez FR, Torres J, et al.Single multiplex polymerase chain reaction to detect diverse loci associated with DiarrheagenicEscherichia coli.Emerg Infect Dis
2003;9: 127–131. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2873745</ArticleId>
            <ArticleId IdType="pubmed">12533296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thong KL, Hoe SLL, Puthucheary SD, Yasin R M. Detection of virulence genes in Malaysian Shigella species by multiplex PCR assay.BMC Infectious Diseases
2005; 5:e8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC551607</ArticleId>
            <ArticleId IdType="pubmed">15707504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dutta S, Yoshiaki K, Takayuki E, Nair GB, Ken-Ichiro I, Shin-Ichi Y. Alteration in the GyrA Subunit of DNA Gyrase and the ParC Subunit of Topoisomerase IV in Quinolone-Resistant Shigella dysenteriae Serotype 1 Clinical Isolates from Kolkata, India. Antimicrob Agents Chemother
2005;49:1660–1661. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1068623</ArticleId>
            <ArticleId IdType="pubmed">15793166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liao CH, Hsueh PR, Jacoby GR, Hooper DC. Risk factors and clinical characteristics of patients with qnr-positive Klebsiella pneumoniae bacteraemia.J AntimicrobChemother
2013; 68: 2907–2914.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3820109</ArticleId>
            <ArticleId IdType="pubmed">23956373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhattacharya D, Bhattacharya H, Thamizhmani R, Sayi DS, Reesu R, Anwesh M, et al.
Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011. Eur J ClinMicrobiol Infect Dis. 2014;33:157–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23990135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ranjbar R, Ghazi FM. Antibiotic Sensitivity Patterns and Molecular Typing of Shigellasonnei Strains Using ERIC-PCR.Iranian J Publ Health, 2013; 42:1151–1157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4436544</ArticleId>
            <ArticleId IdType="pubmed">26060624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mandal J, Ganesh V, Emelda J, Mahadevan S, Parija SC. The recent trends in shigellosis: A JIPMER perspective. J ClinDiagn
2012; 6: 1474–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3527773</ArticleId>
            <ArticleId IdType="pubmed">23285433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mandal J, Poonambath D K, Bhosale N K, Das A. Novel strain of Shigelladysenteriae serotype 7 from India. New Microbe and New Infect
2015; 7: 97–99.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4552805</ArticleId>
            <ArticleId IdType="pubmed">26442152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strockbine NA, Maurelli TA. Shigella In: Brenner DJ, Kreig NR, Staley JT, Garrity GM, editors. Bergey’s manual of systematic bacteriology. 2nd ed
New York: Springer; 2001.  p. 2
 811–823.</Citation>
        </Reference>
        <Reference>
          <Citation>Vargas M, Gascon J, Jimenez de Anta MT, Vila J. Prevalence of Shigellaenterotoxins 1 and 2 among Shigella strains isolated from patients with traveler’sdiarrhea. J ClinMicrobiol
1999;37:3608–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC85705</ArticleId>
            <ArticleId IdType="pubmed">10523561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lamba K, Nelson JA, Kimura AC, Poe A, Collins J, Kao AS, et al.
Shiga Toxin 1–Producing Shigellasonnei Infections, California, United States, 2014–2015. Emerg Infect Dis
2016; 22: 679–686. 10.3201/eid2204.151825
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2204.151825</ArticleId>
            <ArticleId IdType="pmc">PMC4806944</ArticleId>
            <ArticleId IdType="pubmed">26982255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niyogi SK. Shigellosis. The J Microbiol
2005;43:133–143. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15880088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schüller S. Shiga Toxin Interaction with Human Intestinal Epithelium. Toxins
2011; 3: 626–639. 10.3390/toxins3060626
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins3060626</ArticleId>
            <ArticleId IdType="pmc">PMC3202847</ArticleId>
            <ArticleId IdType="pubmed">22069729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim SJ, Kim JJ, Kim SJ, Jeon SE, Seo KY, Choi JK, et al.
Outbreak of Ciprofloxacin-Resistant Shigellasonnei Associated with Travel to Vietnam, Republic of Korea. Emerg Infect Dis
2015; 21: 1247–1250. 10.3201/eid2107.150363
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2107.150363</ArticleId>
            <ArticleId IdType="pmc">PMC4480405</ArticleId>
            <ArticleId IdType="pubmed">26079171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nandy S, Dutta S, Ghosh S, Ganai A, Rajahamsan J, Theodore RBJ, et al.
Foodborne associated Shigellasonnei, India, 2009 and 2010. Emerg Infect Dis
2011; 17: 2072–2074. 10.3201/eid1711.110403
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1711.110403</ArticleId>
            <ArticleId IdType="pmc">PMC3310563</ArticleId>
            <ArticleId IdType="pubmed">22099103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vila J, Ruiz J, Marco F, Barceló A, Goñi P, Giralt E, et al.
Association between double mutation in gyrAgene of ciprofloxacin resistant clinical isolates of Escherichia coli and minimal inhibitory concentration. Antimicrob Agents Chemother
1994;38: 2477–9. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC284767</ArticleId>
            <ArticleId IdType="pubmed">7840592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J AntimicrobChemother 2003; 51: 1109–1117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12697644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar M, Dahiya S, Sharma P, Sharma S, Singh TP, Kapil A, et al.
Structure Based InSilico Analysis of Quinolone Resistance in Clinical Isolates of Salmonella Typhi from India. PLoS ONE
2015;10: e0126560
10.1371/journal.pone.0126560
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0126560</ArticleId>
            <ArticleId IdType="pmc">PMC4427296</ArticleId>
            <ArticleId IdType="pubmed">25962113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poirel L, Cattoir V, Nordmann P. Plasmid-mediated quinolone resistance; interactions between human, animal, and environmental ecologies. Front. Microbiol. 2012;3:1–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3270319</ArticleId>
            <ArticleId IdType="pubmed">22347217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zaidi MB, Estrada-García T, Campos FD, Chim R, Arjona F, Leon M, et al.
Incidence, clinical presentation, andantimicrobial resistance trends in Salmonella and Shigellainfections from children inYucatan, Mexico. Front Microbiol
2013; 4: 1–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3787544</ArticleId>
            <ArticleId IdType="pubmed">24098297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Veldman K, Cavaco LM, Mevius D, Battisti A, Franco A, Botteldoorn N, et al.
International collaborative study on the occurrence of plasmid-mediated quinolone resistance in Salmonella enterica and Escherichia coli isolated from animals, humans, food and the environmentin13European countries. J. Antimicrob. Chemother. 2011; 66:1278–1286. 10.1093/jac/dkr084
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkr084</ArticleId>
            <ArticleId IdType="pubmed">21393198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu PYF, Lau YJ, Hu BS, Shyr JM, Shi ZY, Tsai WS, et al.
Analysis of Clonal Relationships among Isolates of Shigellasonnei by Different Molecular Typing Methods. J ClinMicrobiol
1995;33: 1779–1783.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC228268</ArticleId>
            <ArticleId IdType="pubmed">7545179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kosek M, Yori PPA, Gilman RH, Vela H, Olortegui MP, Chavez C B, et al.
Facilitated Molecular Typing of Shigella Isolates Using ERIC-PCR. Am. J. Trop. Med. Hyg., 86(6), 2012, pp. 1018–1025. 10.4269/ajtmh.2012.11-0671
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4269/ajtmh.2012.11-0671</ArticleId>
            <ArticleId IdType="pmc">PMC3366515</ArticleId>
            <ArticleId IdType="pubmed">22665611</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
